QT prolongation and syncope with methadone, doxepin, and a beta-blocker

Ann Pharmacother. 2005 Oct;39(10):1762-3. doi: 10.1345/aph.1G277. Epub 2005 Sep 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / adverse effects*
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Anxiety Disorders / complications
  • Anxiety Disorders / drug therapy
  • Doxepin / administration & dosage
  • Doxepin / adverse effects*
  • Doxepin / therapeutic use
  • Electrocardiography
  • Humans
  • Long QT Syndrome / chemically induced*
  • Male
  • Methadone / administration & dosage
  • Methadone / adverse effects*
  • Methadone / therapeutic use
  • Substance-Related Disorders / complications
  • Substance-Related Disorders / rehabilitation
  • Syncope / chemically induced*
  • Tachycardia / complications
  • Tachycardia / drug therapy

Substances

  • Adrenergic beta-Antagonists
  • Doxepin
  • Methadone